Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocryst Pharm IncfiledCriticalBiocryst Pharm Inc
Priority claimed from PCT/US2010/061912external-prioritypatent/WO2011079230A2/en
Publication of MX2012006897ApublicationCriticalpatent/MX2012006897A/en
The invention provides compounds of formula (I): (Formula (I)), or a salt thereof as described herein. The invention also provides pharmaceutical compositions comprising a compound of formula (I), processes for preparing compounds of formula (I), intermediates useful for preparing compounds of formula (I) and therapeutic methods for suppressing an immune response or treating cancer or a hematologic malignancy using compounds of formula (I).
MX2012006897A2009-12-232010-12-22Heterocyclic compounds as janus kinase inhibitors.
MX2012006897A
(en)